Файл: Advanced Imaging of the Abdomen - Jovitas Skucas.pdf

pancreas divisum, 504, 506

von Hippel-Lindau disease,

510

diabetes mellitus, 559–560

endoscopic retrograde

cholangiopancreatogra

phy, 562–563

heterotopic, 68, 153

immunosuppression, 560

infection/inflammation,

511–529

acute pancreatitis, 511–518

amyloidosis, 529

chronic pancreatitis,

518–523

clonorchis infestation, 528

complications of

pancreatitis, 523–528

Dengue hemorrhagic fever,

528

focal pancreatitis, 518

iron overload, 529

leptospirosis, 528

lipomatosis, 528–529

sarcoidosis, 529

laparoscopy, 562

magnetic resonance imaging,

502

pancreatography, 502–503

pancreatoscopy, 503

resection, 562

scintigraphy, 503

transplantation, 560–562

complications, 561–562

indications, 560–561

results, 561

trauma, 510–511

tumors, 529–559

benign neoplasms, 530

cystic neoplasms, 544–553

clinical, 544–545

imaging, 545

intraductal mucin-

producing tumors,

550–551

microcystic (serous)

neoplasm, 546

mucinous cystic

neoplasms, 546–550

oncocytic tumors,

551–552

papillary cystic

neoplasms, 552–553

1071

INDEX

511–512

Papilloma

Perianal fistula, 262–263

drug related, 513

bile duct, 467–468

Periarteritis nodosa, 886

endoscopic retrograde

bladder, 696

Peribiliary cysts, 354–355

cholangiopancreatogra

esophagus, 21

Peripheral washout sign, 389

phy induced, 512

kidney, 624

Peritoneal fluid, 871–872

ethanol, 512

pancreas, 530

Peritoneal foreign bodies, 927

infection, 512–513

Papillomatosis

Peritoneal lavage, 781

neoplasm, 513

bile duct, 467–468

Peritoneography, 867–868

vascular, 513

pancreas, 530

Peritoneum, 865–932

imaging, 514–516

Paraduodenal hernia, 923–924

acute abdomen, 876–877

prognosis, 517–518

Paraganglioma, 118, 558

biopsy, 868

therapy, 516–517

bladder, 706–707

computed tomography, 865

autoimmune, 519

Paraovarian/paratubal cysts, 749

congenital abnormalities,

chronic, 518–523

Parapelvic cyst, 604

868–870

calcifications, 522

Paravaginal cysts, 784–785

abdominal wall defects,

classification, 518

Parkinson’s disease, 42

869–870

clinical, 519–520

Pearson marrow-pancreas

diaphragmatic

chronic calcifying, 520

syndrome, 508

abnormalities, 870

chronic obstructive,

Peliosis, 944–945

heterotaxy syndrome,

519–520

Peliosis hepatitis, 348

868–869

idiopathic fibrosing, 519

Pelvic congestion syndrome, 789

Noonan’s syndrome, 870

tropical calcific, 520

Pelvic floor abnormalities,

situs, 868

tuberculous, 520

787–789

diaphragm, 926

etiology, 518–519

Pelvic inflammatory disease, 732

diffuse infiltration, 886–889

imaging, 521–522

Pelvic prolapse, 787–789

amyloidosis, 888

malignant potential, 520

Pelvic vein, 1023

extramedullary

pathology, 520–521

Pemphigoid, 36

hemopoiesis, 888

therapy, 522–523

Penis, 830–834

fibrosis/desmoid, 886–888

complications, 523–528

Cowper’s glands, 832

sarcoidosis, 888

abscess, 526–527

impotence, 833

systemic mast cell disease,

biliary, 526

Peyronie’s disease, 832–833

888–889

fistulas, 524

priapism, 832

xanthogranulomatosis/

gastrointestinal tract, 526

thrombophlebitis, 834

Erdheim-Chester

pseudocyst, 524–526

trauma, 809–810

disease, 888

spleen, 526

tumors, 831–832

ectopic pregnancy, 917–918

vascular, 526–527

urethra, 830–831

endometriosis, 927

focal, 518

Peptic ulcer, 62–63, 109–110

examination and surgical

gallstone, 516–517

Percutaneous jejunostomy, 128

complications

groove, 518

Percutaneous nephrostomy/

biopsy, 929

hemorrhagic, 511

stenting, 575–576

dialysis, 928

lymphoplasmacytic, 519

Percutaneous transhepatic

heterotopic calcifications,

necrotizing, 511, 517

cholangiography,

929–930

sclerotic, 519

422

laparoscopy, 928–929

Pancreatography, 502–503

complications, 497

retained sponges, 929

chronic pancreatitis, 521–522

Perforated cholecystitis, 439

tumor seeding, 929

computed tomography, 503

Perforation

ventriculoperitoneal shunts,

endoscopic, 502

colon, 261

928

magnetic resonance, 503

duodenum, 121–122

fibrosis/adhesions, 925

percutaneous, 503

jejunum and ileum

fistula, 925

Pancreatoscopy, 503

Crohn’s disease, 143–144

fluid collections, 889–898

Papillary endothelial hyperplasia,

traumatic, 137

ascites, 889–892

601–602

small bowel, 137, 173

cysts, 894–896

Peritoneum (cont.)

solid tumors, 898–917

hemangioma, 896

adenopathy, 898–900

hematoma, 893–894

germ cell tumors, 913

hemoperitoneum, 892–893

imaging, 898

lymphangioma, 896–897

inflammatory pseudotumor,

pseudomyxoma peritonei,

904

897–898

lymphangioleiomyomatosis,

urinoma, 892

903

hernias, 918–925

lymphoma, 900–903

diaphragmatic, 918–919

malignant melanoma, 913

Bochdalek hernia,

mesenchymal tumors,

918–919

906–913

Morgagni hernia, 918

epithelioid hemangioen-

femoral hernia, 919

dothelioma, 909–910

incisional hernia, 922

fat-containing tumors,

inguinal hernia, 919–920

910–911

internal hernia, 922–925

hemangiopericytoma,

lumbar hernia, 921–922

911

obturator hernia, 920

histiocytic tumors,

sciatic foramen hernia, 922

912–913

spigelian hernia, 920–921

leiomyomatous tumors,

ventral hernia, 919

911–912

immunosuppression, 927–928

mesothelioma, 907–909

infection/inflammation,

osteogenic tumors,

877–886

913

abscess, 877–880

metastases/carcinomatosis,

abdominal wall, 879

905–906

intraperitoneal, 877–879

neuroendocrine tumors,

psoas muscle abscess,

914–917

879–880

carcinoid, 916–917

echinococcosis, 885

ganglioneuroma, 914

filariasis, 885

neurofibromatous tumors,

parasitic infestation,

915–916

885–886

pheochromocytoma,

peritonitis, 880–883

914–915

in cirrosis, 881

schwannoma, 915

infectious, 880–881

plasmacytoma, 903

lupus, 881

presacral tumors, 917

meconium, 881

primary carcinoma,

sclerosing, 881–883

904–905

vernix caseosa-induced,

small cell carcinoma,

881

913–914

tuberculosis, 883–885

trauma, 870–876

lymphography, 867

barotrauma, 876

magnetic resonance imaging,

bowel injury/perforation,

866

873–874

nerve block, 868

diagnostic peritoneal lavage,

omentum, 926

871

peritoneal foreign bodies, 927

diaphragmatic injury,

peritoneography, 867–868

874–876

pneumoperitoneum, 925–926

imaging, 872–873

pneumoretroperitoneum, 926

penetrating injury, 871

scintigraphy, 866–867

peritoneal fluid, 871–872

INDEX

Polyposis syndromes, 69–70

Positron emission tomography,

mesenchymal, 828–829

Cronkhite-Canada syndrome,

300–301

prostate carcinoma See

70

Postpancreaticoenteric

Prostatic carcinoma

duodenum, 112

anastomosis, 99–100

prostatic and Müllerian

familial polyposis, 70

Postpartum bleeding, 739

cysts, 814

jejunum and ileum, 155

Potter sequence, 576

sclerosing adenosis, 814

juvenile polyposis, 70

Preeclampsia, 737–738

small cell/anaplastic

nonfamilial polyposis, 69–70

Pregnancy

carcinoma, 828

Peutz-Jeghers syndrome, 70

acute cholecystitis, 440–441

Prostatic carcinoma, 814–828

Polyps

antepartum bleeding, 738–739

clinical aspects, 814–817

colon

appendicitis, 287

detection, 818–821

hyperplastic, 217–218

ectopic See Ectopic pregnancy

outcome/follow-up, 827–828

inflammatory fibroid, 218

gestational trophoblastic

pathologic study, 817–818

juvenile, 218

disease, 739–741

staging, 821–825

jejunum and ileum, 143

heterotopic, 737

therapy, 825–827

Polysplenia, 934

liver in, 337–338

Prostatic cysts, 814

Pompe’s disease, 304

normal, 734–735

Prostatitis, 813

Porcelain gallbladder, 448

ovarian hyperstimulation

Prostatodynia, 857

Porta hepatis injury, 312

syndrome, 741

Protein-losing gastroenteropathy,

Portal hypertension, 948–949,

placenta, 738

150

1004–1021

postpartum bleeding, 739

Prune belly syndrome, 869–870

clinical aspects, 1007

preeclampsia, 737–738

Psammoma tumors, 759

collateral veins, 1012–1014

renal failure in, 657

Pseudodiverticulosis, 44

colopathy, 266–267

urinary tract dilatation, 646

Pseudohermaphroditism, 728

etiology and pathogenesis,

uterine dehiscence, 737

Pseudomelanosis duodeni, 120

1005–1007

uterine rupture, 737

Pseudomyxoma peritonei,

gastropathy, 96

Primary biliary cirrhosis,

897–898

imaging, 1007–1008

332–333

Pseudosarcoma, bladder, 695

portal vein cavernous

Primary sclerosing cholangitis,

Pseudoxanthoma elasticum, 661,

transformation,

452–455

988

1011–1012

Proctography, 185–186

Puborectalis syndrome, 260

portal vein obstruction/

Progressive familial intrahepatic

Pyelonephritis

thrombosis, 1008–1012

cholestasis, 431

acute, 591–593

pressure and flow

Progressive supranuclear palsy,

adults, 592–593

measurements,

42

children, 592

1004–1005

Progressive systemic sclerosis,

chronic, 598

therapy, 1014–1021

40–41

emphysematous, 593–594

medical, 1014–1015

Prolapse

Pyeloureteritis cystica, 662

stenting, 1021

pelvic floor, 787–789

Pyocele, 843

surgical, 1015

rectal, 258–260

Pyogenic abscess, 312–313

TIPS, 1015–1021

Prostate, 810–829

Pyogenic cholangitis, 449

Portal vein, 1004–1022

calcifications, 854

Pyometra, 774

aneurysm, 1021

congenital abnormalities, 802

Pyonephrosis, 594

calcification, 1022

hyperplasia/hypertrophy,

cavernous transformation,

810–813

R

1011–1012

clinical, 810–811

Radiation effects

gas, 1021

imaging, 811

bladder, 694

obstruction/thrombosis,

therapy, 812–814

esophagus, 19–20

1008–1012

infection/inflammation,

small bowel, 151

portal hypertension,

813–814

stomach, 65

1004–1021

tumors, 814–829

Radiation hepatitis, 324–325

tumors, 1022

benign neoplasm, 814

Radiation nephritis, 660

Portosystemic shunts, 1012–1014

lymphoma/leukemia, 828

Radiation proctocolitis, 216

Radioembolization, 376

imaging, 654–655

Radiofrequency ablation,

infection, 657

392–393

nephrotic syndrome, 659

Radiofrequency coagulation,

post-bone marrow

377–379

transplantation, 659

Radiography

in pregnancy, 657

appendicitis, 283

rhabdomyolysis, 657

kidneys and ureters, 571

vascular causes, 655

small bowel obstruction,

Renal hypertension, 1027–1036

163–164

nonrenal causes, 1027

Radioimmunotherapy, 240

nonvascular renal causes,

Radiopharmaceuticals, 300

1027–1028

Rectal atresia, 192

renal artery stenosis,

Rectal diverticula, 256

1028–1036

Rectal prolapse, 258–260

Renal varices, 1038

Rectocele, 257–258

Renal vein occlusion, 1037–1038

Rectovaginal fistula, 263

Reninoma, 638

Reflux esophagitis, 12–14

Renin secreting tumor, 764

clinical signs, 12

Renocolic fistula, 263

imaging, 12–13

Replacement lipomatosis, 599

therapy, 13–14

Reproductive system

Renal ablation/embolization,

female See Female

1036

reproductive tract

Renal agenesis, 576

male See Male reproductive

Renal artery

tract

aneurysm, 1036–1037

Retained gastric antrum, 101–102

stenosis, 1028–1036

Rete testis dilatation, 841

clinical, 1029–1030

Reticuloendothelial failure, 337

detection, 1030–1034

Retrocaval ureter, 646

etiology, 1028–1029

Rhabdoid tumor, colon, 246

therapy, 1034–1036

Rhabdomyolysis, 657

Renal carbuncle, 594–595

Rhabdomyosarcoma, 778

Renal colic, 642–644

paratesticular, 853

Renal failure/insufficiency,

Rosai-Dorfman disease, 601

653–659

Rotational abnormalities of

acute cortical necrosis,

bowel, 128–129

655–656

Rotor’s syndrome, 431

acute interstitial nephritis,

656

S

acute tubular necrosis, 655

Salmonella, 147

chronic tubular dysfunction

Salpingitis isthmica nodosa,

disorders, 656–657

733

cirrhosis/hepatorenal

Sarcoidosis, 20, 65–66

syndrome, 659

duodenum, 111

clinical, 653–654

kidney, 653

diabetic nephropathy, 657–658

liver, 337

drug induced, 656

pancreas, 529

focal segmental

peritoneum, 888

glomerulosclerosis,

scrotum, 839

658–659

spleen, 942

glomerulonephritis, 658

stomach, 65–66

hemolytic-uremic syndrome,

Sarcoma

659

bile duct, 479